by Annie De Groot | Jan 11, 2016 | News
PROVIDENCE, R.I., Jan. 11, 2016 /PRNewswire/ — EpiVax, Inc. (EpiVax) today announced the company’s participation in a new venture, Aceno Biotherapeutics, a BioSuperior company. Co-founder Anne S. De Groot MD will be presenting the vision for the new...
by Annie De Groot | Feb 5, 2014 | Thinking Out Loud -Blog
Reducing Immunogenicity with DeFT Engineering EpiVax is highly trusted by drug developers at large and small biopharma world-wide. We have accurately predicted immunogenicity in humans (published) and a major portion of our success is derived from providing...